Skip to main content
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. — Investor Relations & Filings

Ticker · RLAY ISIN · US75943R1023 US Manufacturing
Filings indexed 484 across all filing types
Latest filing 2021-12-28 Director's Dealing
Country US United States of America
Listing US RLAY

About Relay Therapeutics, Inc.

https://relaytx.com/

Relay Therapeutics, Inc. is a clinical-stage precision medicines company focused on transforming the drug discovery process. The company's approach is centered on understanding protein motion, utilizing its proprietary Dynamo® platform which integrates advanced computational and experimental methods. This platform enables the visualization of protein dynamics to design novel therapies for targets that have been historically considered intractable or 'undruggable'. Relay Therapeutics is advancing a pipeline of therapeutic candidates with an initial focus on precision oncology and genetic diseases.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2021-12-28 English
FORM 4 SUBMISSION
Director's Dealing
2021-12-28 English
FORM 3 SUBMISSION
Director's Dealing
2021-12-28 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated December 8, 2021, by Relay Therapeutics, Inc. The key content is the resignation of a Class III director, Dipchand (Deep) Nishar, from the board. This is an announcement of a change in the company's board of directors. There is no financial data or report attached, nor is this a report publication announcement. The document fits the category of Board/Management Information (MANG) as it announces a director departure and related board change.
2021-12-09 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-17 English
FORM 4 SUBMISSION
Director's Dealing
2021-11-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.